Application Nr Approved Date Route Status External Links
NDA017011 2005-08-19 Ophthalmic RX Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

Indications And Usage Prednisolone Acetate Ophthalmic Suspension 1.0% Is Indicated For The Treatment Of Steroid-Responsive Inflammation Of The Palpebral And Bulbar Conjunctiva, Cornea, And Anterior Segment Of The Globe.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Prednisolone Acetate PREDNISOLONE ACETATE ZINC4097474

Comments